Sahin Ugur, BioNTech SE’s chief executive officer, sold 49,000 shares at prices from $96.09 to $96.49 per share on Sep. 15 and Sep. 16, 2026. He retained 553,209 shares afterward, while the reported sales represented about 8.1% of his prior holding.

Key Highlights

  • Sahin Ugur’s post-transaction BioNTech SE holding was 553,209 shares.
  • The reported sales represented about 8.1% of his prior shares holding.
  • BioNTech SE CEO Ugur Sahin sold 49,000 shares.
  • The sales occurred on Sep. 15 and Sep. 16, 2026.

BioNTech SE (NASDAQ: BNTX) Chief Executive Officer Sahin Ugur sold 49,000 shares at prices ranging from $96.09 to $96.49 per share. The transactions involved BioNTech SE stock held by the company’s chief executive officer. Ugur’s transactions took place on Sep. 15 and Sep. 16, 2026. The sales were split across two separate transactions. The reported price range covered $96.09 to $96.49 per share. The combined transaction Volume was 49,000 BioNTech SE shares.

Post-Sale Holding Stood at 553,209 Shares

Ugur owned 553,209 BioNTech SE shares after completing the transactions. The sold shares represented about 8.1% of his prior shares holding in BioNTech SE. BioNTech SE’s chief executive officer therefore had a remaining post-transaction position of 553,209 shares.